Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedA banner about government funding status and NIH operations was added, with links to cc.nih.gov and opm.gov. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data). Introduced a new Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedOnly a minor site revision update is visible, with Revision: v3.3.4 added and Revision: v3.3.3 removed; this change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section has been refreshed with numerous new site entries across the U.S. and internationally. The prior location listings have been removed in favor of the updated, expanded site list.SummaryDifference2%

- Check92 days agoChange DetectedThe Publications section now clarifies that PubMed publications are automatically populated from PubMed. The revision tag has been updated to Revision: v3.3.2, replacing the prior v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.